BioCentury
ARTICLE | Clinical News

Drug-eluting GTX stent: Feasibility study started

November 17, 2008 8:00 AM UTC

Cook's Global Therapeutics unit began an open-label, German feasibility study to evaluate an AVI-5126-eluting GTX stent in up to 90 patients who will undergo a follow-up exam at 30 days and 6 months. ...